Harvey Charles Krasny, American pharmaceutical executive, researcher. Achievements include study of pharmacokinetics, bioavailability and drug metabolism of the antiviral agent acyclovir (Zovirax) in humans; pre-clinical development of AZT (Retrovir).
Krasny, Harvey Charles was born on July 27, 1945 in High Point, North Carolina, United States. Son of Morris Theodore and Elizabeth (Nurkin) Krasny.
Bachelor of Science, Lynchburg (Virginia) College, 1967. Master of Science, University North Carolina, 1969. Doctor of Philosophy, University North Carolina, 1976.
Research biochemist Glaxo Wellcome Inc., Research Triangle Park, North Carolina, 1969-1983, senior research scientist, 1983-1995. Vice president licensing and new business development CaroTech, LLC, since 1995.
Achievements include study of pharmacokinetics, bioavailability and drug metabolism of the antiviral agent acyclovir (Zovirax) in humans. Pre-clinical development of AZT (Retrovir).
Contributor articles to professional journals.
Member American Society Clinical Pharmacology and Therapeutics, American Society Pharmacology and Experimental Therapeutics, Licensing Executives Society, Association of University Technology Managers, Society Toxicology, Sigma Xi (president chapter 1993-1995).